Keeping Up to Date with Ongoing Trials in Gene Therapy for Neurological Disorders

Time: 9:00 am
day: Day Two


  • Overview of the current active clinical and preclinical landscape within gene therapies for neurological disorders along with key regulatory milestones
  • Approval and discontinuation lifecycles
  • Analysis into the disease landscape within neurological disorders, comparing rare vs non-rare disease indications